APA (7th ed.) Citation

A, H., Y, A., A, L., JP, D., T, K., M, P., . . . O, H. (2025). Real-World Outcomes of SGLT2 Inhibitors in Very Elderly Patients With Heart Failure With Preserved Ejection Fraction. JACC. Heart failure, 13(12), 102428. https://doi.org/10.1016/j.jchf.2025.02.011

Chicago Style (17th ed.) Citation

A, Hacil, et al. "Real-World Outcomes of SGLT2 Inhibitors in Very Elderly Patients With Heart Failure With Preserved Ejection Fraction." JACC. Heart Failure 13, no. 12 (2025): 102428. https://doi.org/10.1016/j.jchf.2025.02.011.

MLA (9th ed.) Citation

A, Hacil, et al. "Real-World Outcomes of SGLT2 Inhibitors in Very Elderly Patients With Heart Failure With Preserved Ejection Fraction." JACC. Heart Failure, vol. 13, no. 12, 2025, p. 102428, https://doi.org/10.1016/j.jchf.2025.02.011.